Filatex Fash. (FILATFASH)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹0.18 |
| Market Cap | ₹150.01 Cr |
| P/E Ratio | 43.24 |
| ROCE | 0.63% |
| ROE | 0.12% |
| Dividend Yield | 0% |
| Profit Growth | -80% |
| Debt/Equity | 0.03 |
| Sales Growth | -65.7% |
| Promoter Holding | 19.06% |
| 52-Week Range | ₹0.14 — ₹0.68 |
| Sector | Textiles & Apparels |
| Book Value | ₹2.95 |
Strengths
- Strong balance sheet with low debt/equity of 0.03
- Massive discount to book value: P/B of 0.10 against book value of ₹2.86
- Small market cap of ₹183 Cr creates scope for asset monetisation or restructuring upside
- No dividend obligation, preserving cash for any potential turnaround
Concerns
- Sales collapsed 59.51% and profit fell 98.66%
- Negligible profitability: ROE 0.19% and ROCE 0.63%
- Promoter holding only 19.06%, indicating limited insider conviction
- Piotroski F-Score of 3/9 points to weak fundamental health
AI Analysis
At ₹0.29 per share, Filatex Fashion has a market capitalisation of only ₹183 crore while its book value stands at ₹2.86 per share. That 0.10 price-to-book ratio makes it look like a classic Graham asset play. But Benjamin Graham taught me that a bargain price is only meaningful if the underlying assets can generate earnings. Here the earnings engine has collapsed: sales fell 59.51%, profit fell 98.66%, and the latest quarter shows ₹22 crore of sales with zero net profit. A P/E of 43.24 is therefore a statistical curiosity, not a valuation anchor. The balance sheet is clean, with debt/equity of 0.03, and that is a real strength. But liability discipline is not the same as asset productivity. Return on equity is a mere 0.19% and ROCE is 0.63% - the company earns almost nothing on its stated capital. In a low-margin, competitive garments and apparels industry, such poor returns make me question whether the book value is truly productive or just historical cloth left on the shelf. Promoter holding of 19.06% is another warning; I like owners with significant skin in the game. Add a Piotroski F-score of 3/9 and no dividend, and this is not a business I can classify as a quality compounder. The margin of safety here is apparent, not proven. I would call it an asset play, contingent on operational repair. I would not rush in. I need evidence of stabilising sales, improving margins, and management action to close the gap between market capitalisation and intrinsic asset value. Until then, a 0.10 P/B can remain cheap for a long time.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer